Standardization of pleural effusion-based tumor mutation burden (TMB) estimation using capture-based targeted

Yongfeng Yu1, Lan Shen1, Wenxiang Ji1

  • 1Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Summary

Pleural effusion (PE) samples can reliably assess tumor mutation burden (TMB) using targeted sequencing panels, offering a promising alternative to tissue biopsies for predicting response to immune checkpoint inhibitors (ICIs). This study validates PE as a viable medium for TMB evaluation.

Related Concept Videos